Varian Treatment
Payments companies reported to CMS as associated with Varian Treatment. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Varian Treatment, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Varian Treatment
These are the largest totals companies reported as associated with Varian Treatment. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Daniel Chang | Ann Arbor, MI | Radiation Oncology | $13,087.91 |
| Drew Moghanaki | Los Angeles, CA | Radiation Oncology | $4,731.54 |
| Edward Kim | New York, NY | Vascular & Interventional Radiology | $4,340.00 |
| Joe Chang | Houston, TX | Radiation Oncology | $4,000.00 |
| Andrew Kennedy | Nashville, TN | Radiation Oncology | $2,934.02 |
| Venkatesh Krishnasamy | Birmingham, AL | Vascular & Interventional Radiology | $2,542.13 |
| Jeffrey Bradley | Saint Louis, MO | Radiation Oncology | $2,349.83 |
| Pamela Samson | Saint Louis, MO | Radiation Oncology | $2,176.52 |
| Robert Chin | Los Angeles, CA | Radiation Oncology | $2,088.23 |
| Jianjun Zhang | Houston, TX | Internal Medicine | $2,000.00 |
Prescribed Varian Treatment?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.